Anti-allergic therapies: Effects on eosinophil progenitors

Pharmacology and Therapeutics

Volumn 95, Issue 1, 2002, Pages 63-72

  Baatjes, Adrian J ^a   Sehmi, Roma ^a   Saito, Hiroko ^a   Cyr, Michael M ^a   Dorman, Sandra C ^a   Inman, Mark D ^a   O'Byrne, Paul M ^a   Denburg, Judah A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Allergic inflammation; Corticosteroids; Hematopoiesis; Progenitor cells; Therapy

Indexed keywords

ANTIHISTAMINIC AGENT; BUDESONIDE; CORTICOSTEROID; DESLORATADINE; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROCORTISONE; INTERLEUKIN 11; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR; INTERLEUKIN 6; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PEPTIDOLEUKOTRIENE; TUMOR NECROSIS FACTOR ALPHA; ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; STEROID;

ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; BASOPHIL; CLINICAL TRIAL; COLONY FORMING UNIT; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG MECHANISM; EOSINOPHIL; HEMATOPOIESIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ANIMAL; DRUG ANTAGONISM; EOSINOPHILIA; HEMATOPOIETIC STEM CELL; HYPERSENSITIVITY; IMMUNOLOGY;

ANIMAL; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS, STEROIDAL; EOSINOPHILIA; EOSINOPHILS; HEMATOPOIETIC STEM CELLS; HISTAMINE H1 ANTAGONISTS; HUMAN; HYPERSENSITIVITY; INTERLEUKIN-5; LEUKOTRIENE ANTAGONISTS; ANIMALS; ANTI-INFLAMMATORY AGENTS; HUMANS; STEROIDS;

EID: 0035993452     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(02)00233-4     Document Type: Review

References (104)

1. The mechanism of IL-5 signal transduction
2. Molecular mechanisms of corticosteroid actions
3. The combined effects of all trans retinoic acid and the glucocorticoid, budesonide, on eosinophil differentiation from cord blood-derived CD34+ progenitor cells in vitro
4. Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects
5. Inhaled glucocorticoids for asthma
6. Mechanisms of action of glucocorticoids in asthma
7. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
8. New directions in allergic diseases: Mechanism-based anti-inflammatory therapies
9. Molecular mechanisms of corticosteroids in allergic diseases
10. Anti-inflammatory actions of steroids: Molecular mechanisms
11. Efficacy and safety of inhaled corticosteroids. New developments
12. Stimulation of human eosinophilopoiesis by hydrocortisone in vitro
13. + hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1
14. Effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects
15. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics
16. The role of leukotrienes in asthma and allergic rhinitis
17. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells
18. Stimulation of human myelopoiesis by leukotriene B4
19. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6, and GMCSF
20. Effects of the cysteinyl leukotriene receptor antagonist, montelukast, on eosinophil differentiation in an experimental mouse model of allergic rhinitis
21. Systemic aspects of allergic disease: The role of the bone marrow
22. The effect of desloratadine on eosinophil/basophil progenitors and other inflammatory markers in seasonal allergic rhinitis: A placebo-controlled randomized study
23. Cytokine-induced human basophil/mast cell growth and differentiation in vitro
24. Basophil and mast cell lineages in vitro and in vivo
25. Clonal origin of human basophil/mast cells from circulating multipotent hemopoietic progenitors
26. Increased numbers of circulating basophil progenitors in atopic patients
27. Heterogeneity of human peripheral blood eosinophil-type colonies: Evidence for a common basophil-eosinophil progenitor
28. Interleukin-5 is a human basophilopoietin: Induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood basophil-eosinophil progenitors
29. Hemopoietic mechanisms in allergic airway inflammation
30. Systemic aspects of allergic disease: Bone marrow responses
31. Extrapulmonary effects of inhaled corticosteroids
32. Pharmacokinetics and pharmacodynamics of inhaled corticosteroids
33. Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids
34. Glucocorticoid enhancement of IL-5-induced bone marrow eosinophil progenitor colony formation in vitro
35. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro
36. Modulation of human marrow haematopoiesis by leucotrienes in vitro
37. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes
38. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
39. Alternative agents in asthma
40. Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge
41. Upregulation by glucocorticoids of responses to eosinopoietic cytokines in bone-marrow from normal and allergic mice
42. The effects of inhaled budesonide on circulating eosinophil progenitors and their expression of cytokines after allergen challenge in subjects with atopic asthma
43. 4, increased airway inflammatory cells in subjects with atopic asthma
44. The inflammatory response in asthma exacerbation: Changes in circulating eosinophils, basophils and their progenitors
45. Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors
46. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid
47. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization
48. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness
49. The assessment and treatment of asthma: A conference report
50. Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy
51. Cytokines directly induce degranulation and superoxide production from human eosinophils
52. Bone marrow events in animal models of allergic inflammation and hyperresponsiveness
53. Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice
54. Immunolocalization of CD34 in nasal polyposis. Effect of topical corticosteroids
55. Effect of steroids on immunoglobulin-induced eosinophil degranulation
56. Release of granule proteins from eosinophils cultured with IL-5
57. CD34: Structure, biology, and clinical utility
58. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
59. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals
60. Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis
61. Generation of leukotrienes by purified human lung mast cells
62. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro
63. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma
64. Effects of an antibody to interleukin-5 in a monkey model of asthma
65. Evidence for the role of leukotrienes C4 and D4 as essential intermediates in CSF-stimulated human myeloid colony formation
66. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism
67. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils
68. Leukotrienes in the pathogenesis of asthma
69. The trials and tribulations of IL-5, eosinophils, and allergic asthma
70. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation
71. Apoptosis of eosinophils and lymphocytes in allergic inflammation
72. Peripheral blood basophils, basophil progenitors, and nasal metachromatic cells in allergic rhinitis
73. Basophilic cell progenitors, nasal metachromatic cells, and peripheral blood basophils in ragweed-allergic patients
74. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: The role of specific adhesion molecules and phosphatidylinositol 3-kinase
75. Molecular mechanisms of leukotriene synthesis: The changing paradigm
76. + cells in the bronchial mucosa in asthma: Potential airway eosinophil progenitors
77. Eosinophilia
78. Allergen-induced murine upper airway inflammation: Local and systemic changes in murine experimental allergic rhinitis
79. Pathogenesis of murine experimental allergic rhinitis: A study of local and systemic consequences of IL-5 deficiency
80. Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures
81. Differentiation of human eosinophils. Role in allergic inflammation
82. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects
83. + hemopoietic progenitor cells in atopic subjects
84. + cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation
85. The role of eosinophils in the pathogenesis of asthma
86. Drug therapy: The pharmacology and use of H1-receptor-antagonist drugs
87. Stimulation of human myelopoiesis by leukotrienes B4 and C4: Interactions with granulocyte-macrophage colony-stimulating factor
88. Inhaled corticosteroids: Impact on asthma morbidity and mortality
89. The CD34 antigen: Structure, biology, and potential clinical applications
90. IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists
91. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: Modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody
92. Effects of antihistamines in adult asthma: A meta-analysis of clinical trials
93. Glucocorticoids inhibit cytokine-mediated eosinophil survival
94. The anti-inflammatory effects of cetirizine
95. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner
96. Recombinant human interleukin 5 is a selective eosinophil chemoattractant
97. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators
98. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects
99. An inhaled corticosteroid, budesonide, reduces baseline but not allergen-induced increases in bone marrow inflammatory cell progenitors in asthmatic subjects
100. Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters
101. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors
102. Analysis of the survival of mature human eosinophils: Interleukin-5 prevents apoptosis in mature human eosinophils
103. Glucocorticoids induce basophil apoptosis